Literature DB >> 9032459

Interactions of the alpha2A-adrenoceptor with multiple Gi-family G-proteins: studies with pertussis toxin-resistant G-protein mutants.

A Wise1, M A Watson-Koken, S Rees, M Lee, G Milligan.   

Abstract

The alpha2A-adrenoceptor is the prototypic example of the family of G-protein-coupled receptors which function by activation of 'Gi-like' pertussis toxin-sensitive G-proteins. A number of members of this subfamily of G-proteins are often co-expressed in a single cell type. To examine the interaction of this receptor with individual Gi-family G-proteins the porcine alpha2A-adrenoceptor was transiently transfected into COS-7 cells either alone or with each of wild-type Gi1alpha, Gi2alpha and Gi3alpha or mutations of each of these G-proteins in which the cysteine residue which is the target for pertussis toxin-catalysed ADP-ribosylation was exchanged for a glycine residue. The alpha2-adrenoceptor agonist UK14304 stimulated both high-affinity GTPase activity and the binding of guanosine 5'-[gamma-35thio]-triphosphate (GTP[35S]), when expressed without any additional G-protein. These effects were greatly reduced by pretreatment of the cells with pertussis toxin. Co-expression of each of the wild-type Gi-like G-protein alpha-subunits resulted in enhanced agonist activation of the cellular G-protein population which was fully prevented by pretreatment with pertussis toxin. Co-expression of the receptor along with the cysteine-to-glycine mutations of Gi1alpha, Gi2alpha and Gi3alpha resulted in agonist stimulation of these G-proteins, which was as great as that of the wild type proteins, but now the agonist stimulation produced over that due to the activation of endogenously expressed Gi-like G-proteins was resistant to pertussis toxin treatment. The Cys --> Gly mutations of Gi1alpha, Gi2alpha and Gi3alpha were each also able to limit agonist-mediated stimulation of adenylate cyclase activity. The degree of agonist-mediated activation of the pertussis toxin-resistant mutant of Gi1alpha was correlated highly both with the level of expression of this G-protein and with the level of expression of the alpha2A-adrenoceptor. Half-maximal stimulation of high-affinity GTPase activity of the Cys --> Gly mutants of Gi1alpha, Gi2alpha and Gi3alpha required 10-15-fold higher concentrations of agonist than did stimulation of their wild-type counterparts, consistent with a model in which the affinity of functional interactions of the alpha2A-adrenoceptor with the wild-type G-protein is greater than with the pertussis toxin-resistant mutant G-protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032459      PMCID: PMC1218128          DOI: 10.1042/bj3210721

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Down-regulation of Gi sub-types by prolonged incubation of adipocytes with an A1 adenosine receptor agonist.

Authors:  A Green; J L Johnson; G Milligan
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

2.  Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2.

Authors:  F R McKenzie; G Milligan
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

Review 3.  Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins.

Authors:  G Milligan
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

4.  Sequence analysis of cDNA and genomic DNA for a putative pertussis toxin-insensitive guanine nucleotide-binding regulatory protein alpha subunit.

Authors:  M Matsuoka; H Itoh; T Kozasa; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies.

Authors:  W F Simonds; P K Goldsmith; J Codina; C G Unson; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells.

Authors:  P Gierschik; D Sidiropoulos; K H Jakobs
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

7.  Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain.

Authors:  P Goldsmith; P Gierschik; G Milligan; C G Unson; R Vinitsky; H L Malech; A M Spiegel
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

8.  Identification of a GTP-binding protein alpha subunit that lacks an apparent ADP-ribosylation site for pertussis toxin.

Authors:  H K Fong; K K Yoshimoto; P Eversole-Cire; M I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis.

Authors:  G Koski; W A Klee
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  15 in total

1.  betagamma dimers derived from Go and Gi proteins contribute different components of adrenergic inhibition of Ca2+ channels in rat sympathetic neurones.

Authors:  P Delmas; F C Abogadie; G Milligan; N J Buckley; D A Brown
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

2.  The role of members of the pertussis toxin-sensitive family of G proteins in coupling receptors to the activation of the G protein-gated inwardly rectifying potassium channel.

Authors:  J L Leaney; A Tinker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Endogenous regulator of G-protein signaling proteins modify N-type calcium channel modulation in rat sympathetic neurons.

Authors:  S W Jeong; S R Ikeda
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

4.  Effect of G protein heterotrimer composition on coupling of neurotransmitter receptors to N-type Ca(2+) channel modulation in sympathetic neurons.

Authors:  S W Jeong; S R Ikeda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

5.  Endogenous regulators of G protein signaling proteins regulate presynaptic inhibition at rat hippocampal synapses.

Authors:  H Chen; N A Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

6.  Measurement of agonist-induced guanine nucleotide turnover by the G-protein Gi1alpha when constrained within an alpha2A-adrenoceptor-Gi1alpha fusion protein.

Authors:  A Wise; I C Carr; G Milligan
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

7.  Gi protein activation in intact cells involves subunit rearrangement rather than dissociation.

Authors:  Moritz Bünemann; Monika Frank; Martin J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

8.  Endocytosis following dopamine D2 receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5/PDGFRβ signaling in striatopallidal medium spiny neurons.

Authors:  N Shioda; Y Yabuki; Y Wang; M Uchigashima; T Hikida; T Sasaoka; H Mori; M Watanabe; M Sasahara; K Fukunaga
Journal:  Mol Psychiatry       Date:  2016-12-06       Impact factor: 15.992

9.  Coupling specificity of NOP opioid receptors to pertussis-toxin-sensitive Galpha proteins in adult rat stellate ganglion neurons using small interference RNA.

Authors:  Wojciech Margas; Khaled Sedeek; Victor Ruiz-Velasco
Journal:  J Neurophysiol       Date:  2008-06-18       Impact factor: 2.714

10.  Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor.

Authors:  Kirstie A Bennett; Christopher J Langmead; Alan Wise; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2009-07-22       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.